Investor Relations

VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for people living with immune-inflammatory diseases.

Events & Presentations

More events are coming soon.

Press Releases

March 14, 2023
VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
Read More
March 9, 2023
VBL Therapeutics Announces Closing of Sale of Manufacturing Facility and Certain Related Assets for $7.1 Million in Cash
Read More

Corporate Presentation

presentation
March 14, 2023 8:07 AM EDT

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Chart